Prosecution Insights
Last updated: October 25, 2026

Novel Ip

Technology area: Medical Devices & Mechanical Engineering

42 pending office actions • 24 clients • 36 examiners • 22 art units • 0 of 42 (0%) have an AI response strategy ready • 51 patents granted in the last 365 days

Analysis

Novel IP focuses on Medical Devices & Mechanical Engineering and reports 41 pending office actions across 2226 career applications. Its resolved allowance rate is 88.48%, showing allowance in a substantial majority of resolved matters. The application portfolio is broad, and the pending inventory indicates continuing prosecution work that requires organized docket oversight.

The average of 3.13 office actions per allowance indicates that allowed matters commonly involve multiple examination exchanges. Practitioners can use the allowance rate to frame resolved outcomes and the action average to anticipate response effort. The profile supports an approach that combines portfolio management with careful claim strategy for individual medical-device and mechanical-engineering cases.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=2226 apps, methodology: how we score firms)

88.5%
Allowance Rate
n=2226
+0.54σ
Allowance Rate (norm)
n=2226
3.1
OAs to Allowance
n=1321
-0.11σ
OAs to Allow (norm)
n=1321
1007 days
Time to Allowance
n=1321
+7.6pp
Interview Lift
n=2226
35.2%
RCE Rate
n=2226
1.1%
Appeal Rate
n=2226

Rejection Performance (% of received rejections ultimately overcome)

81.4%
§101 Overcome
n=247
80.2%
§102 Overcome
n=499
82.2%
§103 Overcome
n=901
80.4%
§112 Overcome
n=552

Specialization & Scale

A61B, G01N, G01V
Top CPC Subclasses
34%
Top-3 CPC Share
n=2226
1
Practitioners
n=2226
2226.0
Apps / Practitioner
n=2226

Portfolio Summary

42
Total Pending OAs
23
Non-Final OAs
19
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 17 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

8
Overdue
1
Due this week
5
Due this month
1
Due in next 60 days
2
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 17 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (8)Due ≤ 7 days (1)Due ≤ 30 days (5)Due ≤ 60 days (1)Due later (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

17
Hard (40%)
18
Medium (43%)
7
Easy (17%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 only1 (2%)
§101 + other2 (5%)
§103 only16 (38%)
§112 only5 (12%)
Double-patenting only2 (5%)
Double-patenting + other2 (5%)
Multi-statute (no §101)14 (33%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

5
Life Sciences
12% of docket
0
Information Tech
0% of docket
2
Communications
5% of docket
3
Semiconductors
7% of docket
32
Mechanical / Eng
76% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

420 h
Manual time on pending OAs
84 h
Time saved (low, 20%)
147 h
Time saved (mid, 35%)
3.7 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
FRITH, SEAN A 2 62.5% +26.6%
BEGEMAN, ANDREW W 2 47.1% +19.0%
KLEIN, BROOKE L 2 54.2% +54.2%
THOMAS, ERIC M 2 69.9% +14.7%
TRINH, HONG-VAN N 2 62.8% +57.0%
STUMPFOLL, DANA LYNN 2 54.1% +43.9%
SABOKTAKIN, MARJAN 1 59.1% +14.1%
SHOULDERS, ANNIE LEE 1 74.9% +17.8%
ELSHAER, ALAAELDIN M 1 35.7% +29.8%
MALEVIC, DJURA 1 78.1% +10.1%

Hard Cases (17)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18004711 ADHESIVE PAD FOR RETAINING AN ELECTRODE AGAINST A PATIENT'S SKIN STUMPFOLL, DANA LYNN 187d overdue
18469026 Disposable Tubing Set for an Enteral Feeding System GOLLAMUDI, NEERAJA 126d overdue
18486298 Modular Stimulation System for the Treatment of Gastrointestinal Disorders LEVICKY, WILLIAM J 92d overdue
19170170 METHOD OF TREATING A MATERIAL FORMATION IN AN APPENDAGE KLEIN, BROOKE L 25d overdue
19078825 Systems and Methods for Proximity Based Data Transfer ELSHAER, ALAAELDIN M 5d
18472609 ACOUSTIC SHOCK WAVE THERAPEUTIC METHODS TO CORRECT ARRHYTHMIA PINDERSKI, JACQUELINE M 12d
18344702 System and Method of Assessing a Patient's Visual Function TU, AURELIE H 26d
19186463 Integrated Electrodiagnostic, Physiological and Ultrasound Systems and Methods BEGEMAN, ANDREW W 75d

Interview Candidates (16)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18004711 ADHESIVE PAD FOR RETAINING AN ELECTRODE AGAINST A PATIENT'S SKIN STUMPFOLL, DANA LYNN 187d overdue
18462551 DEVICE FOR TREATING MALIGNANT DISEASES WITH THE HELP OF TUMOR - DESTRUCTIVE MECHANICAL PULSES (TMI) FRITH, SEAN A 87d overdue
19170170 METHOD OF TREATING A MATERIAL FORMATION IN AN APPENDAGE KLEIN, BROOKE L 25d overdue
19078825 Systems and Methods for Proximity Based Data Transfer ELSHAER, ALAAELDIN M 5d
18069531 Foot-Actuated Device for Switching Flow Between Fluid Sources TRINH, HONG-VAN N 28d
19186463 Integrated Electrodiagnostic, Physiological and Ultrasound Systems and Methods BEGEMAN, ANDREW W 75d
19402806 DEVICE FOR TREATING MALIGNANT DISEASES WITH THE HELP OF TUMOR-DESTRUCTIVE MECHANICAL PULSES (TMI) FRITH, SEAN A —
19292756 ACOUSTIC SHOCK WAVE OR PRESSURE PULSE TREATMENT FOR PROPTOSIS OR EXOPHTHALMOS SABOKTAKIN, MARJAN —

Client Portfolio (24 clients)

Top Art Units

Art UnitApps
37946
37975
37984
37154
37913
37833
37922
36871
28841
26681

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19402806 DEVICE FOR TREATING MALIGNANT DISEASES WITH THE HELP OF TUMOR-DESTRUCTIVE MECHANICAL PULSES (TMI) Tissue Regeneration Technologies, LLC FRITH, SEAN A 3798 §103§112 Non-Final OA — Pending Nov 26, 2025
19292756 ACOUSTIC SHOCK WAVE OR PRESSURE PULSE TREATMENT FOR PROPTOSIS OR EXOPHTHALMOS Softwave Tissue Regeneration Technologies, LLC SABOKTAKIN, MARJAN 3797 §112Other Non-Final OA — Pending Aug 06, 2025
19232563 Duodenal Ablation with Improved Depth and Consistency of Ablation Aqua Medical, Inc. SHOULDERS, ANNIE LEE 3794 §112 Non-Final OA — Pending Jun 09, 2025
19186463 Integrated Electrodiagnostic, Physiological and Ultrasound Systems and Methods Cadwell Laboratories, Inc. BEGEMAN, ANDREW W 3798 §103§112 Final Rejection 75d Pending Apr 22, 2025
19170170 METHOD OF TREATING A MATERIAL FORMATION IN AN APPENDAGE Softwave Tissue Regeneration Technologies, LLC KLEIN, BROOKE L 3797 §102§103Other Non-Final OA 25d overdue Pending Apr 04, 2025
19090799 ACOUSTIC SHOCK WAVE TREATMENT AND DEVICES FOR APPENDAGES Softwave Tissue Regeneration Technologies, LLC KLEIN, BROOKE L 3797 §102§103§112DP Non-Final OA — Pending Mar 26, 2025
19078825 Systems and Methods for Proximity Based Data Transfer Spacelabs Holdings, Inc. ELSHAER, ALAAELDIN M 3687 §102§103 Final Rejection 5d Pending Mar 13, 2025
18963250 Methods and Systems for Dynamically Selecting and Modifying Digital Assets Within Game Elements of a Multiplayer Video Game Activision Publishing, Inc. THOMAS, ERIC M 3715 §101§103DP Non-Final OA — Pending Nov 27, 2024
18951358 METHOD FOR DETERMINING THE NEUTRON FLUX BY USING A PORTABLE RADIONUCLIDE IDENTIFICATION DEVICE (RID) COMPRISING SCINTILLATION MATERIAL WITH IODINE Target Systemelektronik GmbH & Co. Kg MALEVIC, DJURA 2884 §103 Non-Final OA — Pending Nov 18, 2024
18907055 Heated Vapor Ablation Systems and Methods for Treating Cardiac Conditions Aqua Heart, Inc. PEFFLEY, MICHAEL F 3794 DP Non-Final OA — Pending Oct 04, 2024
18807066 Using Data from a Body Worn Sensor to Modify Monitored Physiological Data Spacelabs Healthcare LLC EISEMAN, ADAM JARED 3791 §103§112Other Non-Final OA — Pending Aug 16, 2024
18802141 Methods and Systems for the Efficient Acquisition, Conversion, and Display of Pathology Images International Medical Solutions, Inc. ABDI, AMARA 2668 §103Other Non-Final OA — Pending Aug 13, 2024
18794105 Systems and Methods for Dynamically Generating and Modulating Music Based on Gaming Events, Player Profiles and/or Player Reactions Activision Publishing, Inc. THOMAS, ERIC M 3715 §101 Final Rejection — Pending Aug 05, 2024
18779513 Hemodynamic Assist Device Sanjaya Khanal HULBERT, AMANDA K 3792 DP Final Rejection 147d overdue Pending Jul 22, 2024
18759697 Method and Apparatus for Treating Topical Wounds Starch Medical, Inc. BROWN, SETH RICHARD 3786 §103 Non-Final OA 35d Pending Jun 28, 2024
18745644 Methods and Systems for Attaching Detectors to Electronic Readout Substrates Rapiscan Systems, Inc. FREEMAN, JOHN D 1787 §103 Non-Final OA — Pending Jun 17, 2024
18733574 Systems and Methods for Controlling Camera Perspectives, Movements, and Displays of Video Game Gameplay Activision Publishing, Inc. MYHR, JUSTIN L 3715 §103 Final Rejection — Pending Jun 04, 2024
18640046 ACOUSTIC SHOCK WAVE OR PRESSURE PULSE TREATMENT AND METHODS OF USE FOR TISSUE REGENERATION Softwave Tissue Regeneration Technologies, Inc. CWERN, JONATHAN 3797 §103§112 Final Rejection — Pending Apr 19, 2024
18634792 Detachable Connector Receptacles Cadwell Laboratories, Inc. JIMENEZ, OSCAR C 2831 §102§103 Non-Final OA — Pending Apr 12, 2024
18614443 Systems and Methods for Enabling Patients to Flexibly, Rapidly and Independently Access Eye Exams Radius Xr, LLC PINKNEY, DAWAYNE 2872 §103 Final Rejection — Pending Mar 22, 2024
18411248 Methods for Preserving and Administering Pre-Beta High Density Lipoprotein Having a Predetermined Minimum Level of Degradation Hdl Therapeutics, Inc. MOAZZAMI, NAGHMEH NINA 1654 §103§112DP Non-Final OA — Pending Jan 12, 2024
18410127 Methods and Systems for Generation, Use, and Delivery of Activated Stem Cells Todd Frank Ovokaitys HUH, VYNN V 3792 §103 Final Rejection 146d overdue Pending Jan 11, 2024
18392774 Hydroponic Cultivation System and Grow Tower Produced Incorporated NGUYEN, TRINH T 3644 §103 Final Rejection — Pending Dec 21, 2023
18528239 Computer-Implemented Methods for Optimized Generation and Selection of Level of Detail Assets for Rendering During Gameplay Activision Publishing, Inc. BODENDORF, ANDREW 3715 §102§103§112 Non-Final OA — Pending Dec 04, 2023
18486298 Modular Stimulation System for the Treatment of Gastrointestinal Disorders Endostim, Inc. LEVICKY, WILLIAM J 3796 §102§103 Final Rejection 92d overdue Pending Oct 13, 2023
18480711 METHODS TO TREAT CANCER AND VACCINATE FROM CANCEROUS CELL RECURRENCE Softwave Tissue Regeneration Technologies, LLC JOHANSEN, PETER N. 1644 §112 Non-Final OA — Pending Oct 04, 2023
18472609 ACOUSTIC SHOCK WAVE THERAPEUTIC METHODS TO CORRECT ARRHYTHMIA Tissue Regeneration Technologies, LLC PINDERSKI, JACQUELINE M 3785 §103§112 Final Rejection 12d Pending Sep 22, 2023
18469026 Disposable Tubing Set for an Enteral Feeding System Generica Medical International, Inc. GOLLAMUDI, NEERAJA 3783 §103§112 Non-Final OA 126d overdue Pending Sep 18, 2023
18462551 DEVICE FOR TREATING MALIGNANT DISEASES WITH THE HELP OF TUMOR - DESTRUCTIVE MECHANICAL PULSES (TMI) Tissue Regeneration Technologies, LLC FRITH, SEAN A 3798 §103 Final Rejection 87d overdue Pending Sep 07, 2023
18344702 System and Method of Assessing a Patient's Visual Function Cadwell Laboratories, Inc. TU, AURELIE H 3791 §103§112 Final Rejection 26d Pending Jun 29, 2023
18321155 Apparatus, System and Method for Performing a Bronchoscopy Thoracent, Inc. TRINH, HONG-VAN N 3783 §103 Non-Final OA — Pending May 22, 2023
18183350 Integrated Electrodiagnostic and Ultrasound Device Cadwell Laboratories, Inc. MOHAMMED, SHAHDEEP 3797 §103 Final Rejection 59d overdue Pending Mar 14, 2023
18004711 ADHESIVE PAD FOR RETAINING AN ELECTRODE AGAINST A PATIENT'S SKIN Seer Medical Pty Ltd. STUMPFOLL, DANA LYNN 3794 §102§103§112 Final Rejection 187d overdue Pending Jan 09, 2023
18069531 Foot-Actuated Device for Switching Flow Between Fluid Sources Thoracent, Inc. TRINH, HONG-VAN N 3783 §112 Non-Final OA 28d Pending Dec 21, 2022
17805839 Methods for Treating Cholesterol-Related Diseases Hdl Therapeutics, Inc. BALLARD, KIMBERLY 1675 §101§102§103§112 Non-Final OA — Pending Jun 07, 2022
17455537 Systems and Methods for Selective Tissue Ablation Santa Anna Tech LLC STUMPFOLL, DANA LYNN 3794 §103§112 Final Rejection — Pending Nov 18, 2021
17450273 Visualization-Enabled Ablation Catheters, Systems, and Methods Santa Anna Tech LLC BROWN, KYLE MARTZ 3794 §103 Non-Final OA 70d Pending Oct 07, 2021
17229515 Methods and Systems for Determining Body Composition of Biological Bodies Using a Resonant Cavity Kotowski, Andreas F. BEGEMAN, ANDREW W 3798 §103 Final Rejection — Pending Apr 13, 2021
17150188 Vapor Ablation System with Simplified Control Over Vapor Delivery Aqua Medical, Inc. LANCASTER, LINDSAY REGAN 3794 §103 Final Rejection 29d Pending Jan 15, 2021
17012410 Multi-Modal Plasma Delipidation Systems Hdl Therapeutics, Inc. PATEL, PRANAV N 1777 §103 Non-Final OA — Pending Sep 04, 2020
16555730 SYSTEMS AND METHODS FOR CONCURRENTLY DISPLAYING SELECTED AND UNSELECTED EEG DATA Cadwell Laboratories, Inc. WEARE, MEREDITH H 3791 §112 Non-Final OA 14d Pending Aug 29, 2019
15482544 Methods and Systems for Obtaining, Analyzing, and Generating Vision Performance Data and Modifying Media Based on the Vision Performance Data Sphairos, Inc. MCCULLEY, RYAN D 2611 §103 Final Rejection — Pending Apr 07, 2017

Managing Novel Ip's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

What is Novel Ip's patent allowance rate?

88.5% of resolved applications prosecuted by Novel Ip were allowed, across 2,226 applications in USPTO records.

How many office actions does Novel Ip average before allowance?

3.13 office actions per allowed application on average.

How many pending office actions does Novel Ip have?

42 pending office actions as of October 2026, for 24 clients, before 36 examiners in 22 art units.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month